BxPC-3, AsPC-1, and PANC-1 cells (5,000) were plated (4 wells/condition) in a 96 well tissue culture dish and incubated for 24 hours. The pancreatic cancer cells were treated as described
in the wound healing assay section. After the cells were serum starved in the appropriate medium supplemented with 0.5% FBS and 1% Penicillin/Streptomycin (P/S) for 24-hours, medium supplemented with 10% FBS or with 100ng/ml of EGF was added to the cells. (MTT reagent) Absorbance was determined at 0, 24, 48, and 72 hours after addition of supplemented media using the SpectraMax M2 e Molecular Devices (Sunnyvale, Ca). Cell viability fold change was calculated using the average absorbance for each treatment group at 24, 48, or 72 hours divided by the initial absorbance at time zero. Percent viability was calculated using the average absorbance for each treatment divided by the average absorbance for the cells not treated with virus and multiplied by 100. Statistical significance was assessed using Student's t-test by Prism V6.0c.
Verification of RGS16 expression in cells treated with Ad.GFP.RGS16
BxPC-3, PANC-1, and AsPC-1 cells were treated with or without adenoviruses Ad.GFP and Ad.GFP.RGS16 as explained in the wound healing assay section of material and methods. 
